Intervention not reported
Adverse events · children and adults with cystic fibrosis
1 finding from 1 review
- no estimate extracted2 studies · 922 participantsVery low
Findings
What do systematic reviews say?
4,918 questions · 5,537 findings · 1,803 reviews
No studies found 1,309 · 23.6%GRADE not reported 440 · 7.9%Very low 1,560 · 28.2%Low 1,292 · 23.3%Moderate 751 · 13.6%High 185 · 3.3%
Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
Summary of findings ‐ nebulisers for delivering dornase alfa conventional system vs AAD
Adverse events · children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Summary of findings ‐ nebulisers for delivering dornase alfa conventional system vs VMT
Adverse events · adults and children with cystic fibrosis
1 finding from 1 review
- no estimate extracted1 study · 85 participantsVery low
Intervention not reported
Adverse events · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Summary of findings ‐ nebulisers for delivering other aerosolised medications: conventional systems vs AAD
Adverse events · adults with cystic fibrosis
1 finding from 1 review
- no estimate extracted1 study · 6 participantsVery low
Summary of findings ‐ nebulisers for delivering other aerosolised medications: VMT and AAD tidal breathing mode (TBM) vs VMT and AAD target inhalation mode (TIM)
Adverse events · adults with cystic fibrosis
1 finding from 1 review
- no estimate extracted1 study · 15 participantsVery low
Summary of findings ‐ nebulisers for delivering other aerosolised medications: conventional systems vs nebuliser
Adverse events · adults and children with cystic fibrosis
1 finding from 1 review
- no estimate extracted1 study · 8 participantsVery low
Angiotensin‐converting enzyme inhibitors vs ARB
Adverse events · adults with early (stage 1 to 3) non‐diabetic CKD
The review found no eligible studies for this question.
1 finding from 1 review
- Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3)… 2023 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Summary of findings: ACBT vs PEP mask therapy
Adverse events · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Summary of findings: ACBT vs OD
Adverse events · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Summary of findings: ACBT vs other breathing techniques
Adverse events · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Summary of findings: ACBT vs CCPT
Adverse events · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Summary of findings: ACBT vs exercise
Adverse events · adults and children with cystic fibrosis
1 finding from 1 review
- no estimate extracted1 study · 19 participantsVery low
Engagement of community leaders vs usual care
Adverse events · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
- Interventions for improving coverage of childhood immunisation in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Health education vs usual care
Adverse events · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
- Interventions for improving coverage of childhood immunisation in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Monetary incentives vs usual care
Adverse events · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
- Interventions for improving coverage of childhood immunisation in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Home‐based record combined with other interventions vs usual care
Adverse events · children aged 1 year
The review found no eligible studies for this question.
1 finding from 1 review
- Interventions for improving coverage of childhood immunisation in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Digital register vs usual care
Adverse events · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
- Interventions for improving coverage of childhood immunisation in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Phone call/SMS with/without combination with monetary incentives vs usual care
Adverse events · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
- Interventions for improving coverage of childhood immunisation in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Wearable reminders vs usual care
Adverse events · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
- Interventions for improving coverage of childhood immunisation in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found